Latest Headlines

  1. Eli Lilly To Build New $3.5B Injectable Drug Manufacturing Site Supporting GLP-1 Therapies In Pennsylvania 2/2/2026

    Eli Lilly and Company (NYSE: LLY) today announced plans to invest more than $3.5 billion in a new manufacturing facility in the Lehigh Valley, Pennsylvania.

  2. Veranova Appoints Jacquelyn Martin As Chief Quality Officer 1/28/2026
  3. Halo Pharma To Become A Stand-Alone Drug Product Contract Development And Manufacturing Organization (CDMO) 1/27/2026

    Halo Pharma, a leading CDMO specializing in drug product pharmaceutical development and manufacturing services, will become a stand-alone business as a result of the sale of the Noramco API and associated businesses to Siegfried.

  4. Eurofins CDMO Alphora Announces Development & Implementation Of AI-Powered Salt And Co-Crystal Screening Software 1/26/2026

    Developed by Eurofins CDMO Alphora, in collaboration with a local university, this cutting-edge machine learning platform provides highly accurate predictions of salt and co-crystal formation for APIs and intermediates.

  5. Coating Place Announces Leadership Appointments To Support Next Phase Of Growth 1/23/2026

    As Coating Place celebrates its 50th anniversary, the company continues to build on its long-standing reputation as the industry leader in Wurster-based fluid bed technology for controlled release and taste masking applications.

  6. Mikart Celebrates 50 Years Of Excellence In Pharmaceutical Manufacturing 1/22/2026

    Mikart, a leading Contract Development and Manufacturing Organization (CDMO) specializing in small-molecule pharmaceutical products, proudly celebrates its 50th anniversary. Since its founding in 1975, Mikart has been dedicated to delivering innovative solutions, quality manufacturing, and outstanding service to its clients in the pharmaceutical industry.

  7. Mikart Signs Lease For New Headquarters At Cumberland Center II In Northwest Atlanta 1/22/2026

    Mikart, a leading contract development and manufacturing organization (CDMO), today announced that it has signed a lease for new headquarters space at the Cumberland Center II, a premier office tower in the Cumberland-Galleria region of Northwest Atlanta. The newly leased facility, encompassing approximately 13,000 square feet, will house Mikart’s administrative and corporate functions.

  8. Genentech To Double Its Investment At North Carolina Drug Manufacturing Facility 1/22/2026

    Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced an expansion of its initial investment in a new Holly Springs, North Carolina manufacturing facility. The increased investment will more than double the total commitment for the company’s first-ever East Coast manufacturing facility to approximately $2 billion.

  9. CDMO Alcami Expands RTP Footprint With New Durham Facility And Major Lab Expansion 1/20/2026

    Alcami Corporation, a leading U.S.-based contract development and manufacturing organization (CDMO), has acquired a 37,000-square-foot facility at 4620 Creekstone Drive in Durham, North Carolina. This $6.7 million investment strengthens Alcami's presence in the Research Triangle region and supports the company's continued expansion of advanced laboratory services.

  10. Wilmington PharmaTech Appoints Seasoned Commercial Leader To Drive Growth 1/16/2026

    Wilmington PharmaTech (“WPT”), a U.S.-based specialty contract research, development and manufacturing organization (CRDMO) focused on complex custom small molecule API, today announced that it has appointed Mike Shearer to the role of Chief Commercial Officer, where he will play a pivotal role in driving growth, strengthening client partnerships, and furthering the organization’s position as a trusted partner for API development and manufacturing. Shearer will report to Hui-Yin “Harry” Li, Ph.D., WPT’s Founder and CEO.